Uppsala, Sweden

Eva M Persson

This inventor holds 1 USPTO granted patent. Top assignee: Astra Aktiebolag. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eva M Persson: Innovator in Pharmaceutical Chemistry

Introduction

Eva M Persson is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target disorders in the central nervous system (CNS). Her work has led to advancements in the treatment of various neurological conditions.

Latest Patents

Eva M Persson holds a patent for a compound known as 8-substituted-2-aminotetralins. This compound is characterized by a specific formula where Z can be hydrogen or halogen, and Q can be COR or a 5- or 6-membered aryl that may contain heteroatoms. The patent also covers processes for the preparation of these compounds, pharmaceutical preparations containing them, and their use in treating CNS disorders. She has 1 patent to her name.

Career Highlights

Eva M Persson is currently associated with Astra Aktiebolag, a leading pharmaceutical company. Her role involves research and development of innovative compounds that can improve patient outcomes in the field of neurology. Her expertise and dedication have made her a valuable asset to her team and the industry.

Collaborations

Throughout her career, Eva has collaborated with several talented individuals, including Ye Liu and Eva C Mellin. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Eva M Persson is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of CNS disorders significantly. Her contributions and collaborations continue to drive innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…